4
Views
3
CrossRef citations to date
0
Altmetric
Original Article

The Fate of Kidney-Transplanted Patients with A Previous History of Malignancy

The Scandinavian Material

Pages 283-286 | Received 20 Jun 1981, Published online: 15 Feb 2010

REFERENCES

  • Belzer, F. O., Schweizer, R. T., Kountz, S. L. & De-Lorimier, A. A. 1972. Malignancy and immunosuppression. Renal homotransplantation in patients with primary renal neoplasms. Transplantation 13, 164–170.
  • Birkeland, S. A., Kemp, E. & Hauge, M. 1975. Renal transplantation and cancer. The Scandia Transplant material. Tissue Antigens 6, 28–36.
  • Birkeland, S. A., Kemp, E. & Hauge, M. 1977. Cancer as a late-onset complication of kidney transplantation. Scand J Urol Nephrol, Suppl. 42, 179–183.
  • Birkeland, S. A., Kemp, E. & Hauge, M. 1980. Renal transplantation and cancer in the Scandiatransplant material. Scand J Urol Nephrol, Suppl. 54, 11–15.
  • Evans, S. B. & Calne, R. Y. 1974. Renal transplantation in patients with carcinoma. Br Med J iv, 134–136.
  • Hoover, R. & Fraumeni, J. F. 1973. Risk of cancer in renal-transplant recipients. Lancet, ii, 55–57.
  • Matas, A. J., Simmons, R. L., Buselmeier, T. J., Kjellstrand, C. M. & Najarian, J. S. 1975. Successful renal transplantation in patients with prior history of malignancy. Am J Med 59, 791–795.
  • Penn, I. 1978. Development of cancer in transplantation patients. Adv Surg 12, 155–191.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.